Literature DB >> 24997241

Intrastriatal GDNF gene transfer by inducible lentivirus vectors protects dopaminergic neurons in a rat model of parkinsonism.

Sha-Sha Chen1, Chun Yang1, Fei Hao1, Chen Li1, Tao Lu1, Li-Ru Zhao2, Wei-Ming Duan3.   

Abstract

Glial cell line-derived neurotrophic factor (GDNF) has neuroprotective effects on dopaminergic (DA) neurons both in vivo and in vitro. However, substantial evidence has shown that a long-term overexpression of GDNF gene is often associated with side effects. We previously improved tetracycline (Tet)-On lentivirus system carrying human GDNF (hGDNF) gene, and demonstrated that hGDNF gene expression was tightly regulated and functional in vitro. Here we further examined the efficiency and neuroprotection of Tet-On lentivirus-mediated hGDNF gene regulation in neural progenitor cells (NPCs) and a rat model of parkinsonism. The results showed that hGDNF gene expression was tightly regulated in transduced NPCs. Doxycycline (Dox)-induced hGDNF protected DA neurons from 6-hydroxydopamine (6-OHDA)-induced toxicity in vitro. Intrastriatal injections of Tet-On lentivirus vectors resulted in dramatically increased levels of hGDNF protein in the striatum of rats with Dox-drinking water, when compared to lentivirus-injected and saline-injected rats with normal drinking water, respectively. In addition, hGDNF protected nigral DA neurons and striatal DA fibers, and attenuated d-amphetamine-induced rotational asymmetry in the 6-OHDA lesioned rats. To the best of our knowledge, this is the first report that hGDNF gene transfer by Tet-On lentivirus vectors is tightly regulated in rat brain, and Dox-induced hGDNF is functional in neuroprotection of nigral DA neurons in a rat model of parkinsonism.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dopaminergic neurons; Gene transfer; Glial cell line-derived neurotrophic factor; Lentivirus vectors; Parkinson's disease; Striatum

Mesh:

Substances:

Year:  2014        PMID: 24997241     DOI: 10.1016/j.expneurol.2014.06.022

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  7 in total

1.  GPR30 Activation Contributes to the Puerarin-Mediated Neuroprotection in MPP+-Induced SH-SY5Y Cell Death.

Authors:  Yue-Fa Cheng; Guoqi Zhu; Qing-Wen Wu; Yue-Sheng Xie; Yan Jiang; Lan Guo; Ya-Li Guan; Ying-Shuo Liu; Jun Zhang
Journal:  J Mol Neurosci       Date:  2016-10-30       Impact factor: 3.444

2.  Doxycycline Used for Control of Transgene Expression has its Own Effects on Behaviors and Bcl-xL in the Rat Hippocampus.

Authors:  G T Shishkina; D A Lanshakov; A V Bannova; T S Kalinina; N P Agarina; N N Dygalo
Journal:  Cell Mol Neurobiol       Date:  2017-08-31       Impact factor: 5.046

3.  Preferential Heme Oxygenase-1 Activation in Striatal Astrocytes Antagonizes Dopaminergic Neuron Degeneration in MPTP-Intoxicated Mice.

Authors:  Xiaofeng Xu; Ning Song; Ranran Wang; Hong Jiang; Junxia Xie
Journal:  Mol Neurobiol       Date:  2015-09-18       Impact factor: 5.590

Review 4.  Parkinson's disease and enhanced inflammatory response.

Authors:  Iva Stojkovska; Brandon M Wagner; Brad E Morrison
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-13

5.  The lentiviral-mediated Nurr1 genetic engineering mesenchymal stem cells protect dopaminergic neurons in a rat model of Parkinson's disease.

Authors:  Xiaoxiao Wang; Wenxin Zhuang; Wenyu Fu; Xiaocui Wang; E Lv; Fengjie Li; Shuanhu Zhou; Wolf-Dieter Rausch; Xin Wang
Journal:  Am J Transl Res       Date:  2018-06-15       Impact factor: 4.060

6.  Induction of GDNF and GFRα-1 Following AAV1-Rheb(S16H) Administration in the Hippocampus in vivo.

Authors:  Dongyoung Yun; Min-Tae Jeon; Hyung-Jun Kim; Gyeong Joon Moon; Shinrye Lee; Chang Man Ha; Minsang Shin; Sang Ryong Kim
Journal:  Exp Neurobiol       Date:  2020-04-30       Impact factor: 3.261

7.  GDNF Promotes Survival and Therapeutic Efficacy of Human Adipose-Derived Mesenchymal Stem Cells in a Mouse Model of Parkinson's Disease.

Authors:  Shoujia Sun; Quan Zhang; Man Li; Pan Gao; Kuan Huang; Rajluxmee Beejadhursing; Wei Jiang; Ting Lei; Mingxin Zhu; Kai Shu
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.